Gene · 7296
Papers4,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 4,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unraveling the Role of Epithelial-Mesenchymal Transition in Adenoid Cystic Carcinoma of the Salivary Glands: A Comprehensive Review. | Cancers (Basel) | 2023 | 37296849 | PubTator, text mining | PubMed |
| Modulation of NRF2/KEAP1 Signaling in Preeclampsia. | Cells | 2023 | 37296665 | PubTator, text mining | PubMed |
| Wide identification of chemical constituents in fermented licorice and explore its efficacy of anti-neurodegeneration by combining quasi-targeted metabolomics and in-depth bioinformatics. | Front Neurosci | 2023 | 37274217 | PubTator, text mining | PubMed |
| PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response. | Front Oncol | 2023 | 37260977 | PubTator, text mining | PubMed |
| A metabolic map of the DNA damage response identifies PRDX1 in the control of nuclear ROS scavenging and aspartate availability. | Mol Syst Biol | 2023 | 37259925 | PubTator, text mining | PubMed |
| Distinct Role of Lycium barbarum L. Polysaccharides in Oxidative Stress-Related Ocular Diseases. | Pharmaceuticals (Basel) | 2023 | 37259363 | PubTator, text mining | PubMed |
| A homozygous mutation in the human selenocysteine tRNA gene impairs UGA recoding activity and selenoproteome regulation by selenium. | Nucleic Acids Res | 2023 | 37254812 | PubTator, text mining | PubMed |
| β-Sitosterol as a Promising Anticancer Agent for Chemoprevention and Chemotherapy: Mechanisms of Action and Future Prospects. | Adv Nutr | 2023 | 37247842 | PubTator, text mining | PubMed |
| A Polygenic Risk Score for Predicting Racial and Genetic Susceptibility to Prurigo Nodularis. | J Invest Dermatol | 2023 | 37245863 | PubTator, text mining | PubMed |
| Development of an assay pipeline for the discovery of novel small molecule inhibitors of human glutathione peroxidases GPX1 and GPX4. | Redox Biol | 2023 | 37244126 | PubTator, text mining | PubMed |
| Emerging Roles of Mesenchymal Stem/Stromal-Cell-Derived Extracellular Vesicles in Cancer Therapy. | Pharmaceutics | 2023 | 37242693 | PubTator, text mining | PubMed |
| New Organometallic Ru(II) Compounds with Lonidamine Motif as Antitumor Agents. | Pharmaceutics | 2023 | 37242608 | PubTator, text mining | PubMed |
| Comprehensive Insights into Medicinal Research on Imidazole-Based Supramolecular Complexes. | Pharmaceutics | 2023 | 37242590 | PubTator, text mining | PubMed |
| Translational Research on Bee Pollen as a Source of Nutrients: A Scoping Review from Bench to Real World. | Nutrients | 2023 | 37242296 | PubTator, text mining | PubMed |
| The Triterpenoid Nrf2 Activator, CDDO-Me, Decreases Neutrophil Senescence in a Murine Model of Joint Damage. | Int J Mol Sci | 2023 | 37240121 | PubTator, text mining | PubMed |
| Redox Signaling Modulates Activity of Immune Checkpoint Inhibitors in Cancer Patients. | Biomedicines | 2023 | 37238995 | PubTator, text mining | PubMed |
| Selenium and Selenoproteins in Health. | Biomolecules | 2023 | 37238669 | PubTator, text mining | PubMed |
| COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics. | Antioxidants (Basel) | 2023 | 37237997 | PubTator, text mining | PubMed |
| Antioxidant and Immune-Related Implications of Minerals in COVID-19: A Possibility for Disease Prevention and Management. | Antioxidants (Basel) | 2023 | 37237970 | PubTator, text mining | PubMed |
| Peroxiredoxin 2: An Important Element of the Antioxidant Defense of the Erythrocyte. | Antioxidants (Basel) | 2023 | 37237878 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7296/papers?page=31